-
+2 +2
Identifying MS Gene Mutations Could Make Personalized Treatment Possible
Read about how a mutation is associated with non-response to IFNβ treatment.
-
+10 +2
5 Awful Realities Of Life With An 'Invisible Illness'
If you have ever had the plague, no one accused you of faking it to get handicapped parking for your oxen or whatever. Not the case with my particular disease.
-
+2 +2
Permeability of the blood–brain barrier predicts conversion from optic neuritis to multiple sclerosis
These findings suggest that blood–brain barrier permeability, as measured by magnetic resonance imaging, may provide novel pathological information as a marker of neuroinflammation related to multiple sclerosis, to some extent reflecting cellular permeability of the blood–brain barrier, whereas T2 lesion count may more reflect the length of the subclinical pre-relapse phase.
-
+8 +2
Lesion Topography Matters in Multiple Sclerosis
Location in cerebral cortex, more than global white matter lesion volume, tied to disability.
-
+8 +2
Study on French MS Population Reveals Long Disease Duration is Associated with Higher Mortality
A study recently published in the journal PLoS One revealed an excess mortality rate among French patients with multiple sclerosis (MS) that experience the disease for more than 20 years.
-
+2 +2
Study Evaluates Gilenya's Impact on Central Autonomic Dysfunction In MS With Delayed Heart Rate
In a recent study published in the Journal PLOS One, a team of researchers found that the autonomic cardiovascular dysfunction in MS patients with delayed heart ratere-acceleration upon Fingolimod-initiation suggest that MS-related central autonomic lesions may compromise heart rate re-acceleration.
-
+2 +2
Biogen Reports Another Tecfidera PML Case
Non-fatal case is the second one for the oral MS drug.
-
+5 +2
Parasites by Post: The Online Black Market for Therapeutic Worms
Some swear by Helminthic therapy, infesting themselves with parasitic worms to treat autoimmune and inflammatory conditions—except the treatment is far from doctor approved.
-
+2 +2
Multiple Sclerosis Research: Bye Bye Yuti
One of the instrumental researchers behind interferon beta therapy is retiring.
-
+2 +2
Study Shows Skin Problems Can Be Caused by Interferon-β MS Therapy
Skin problems may be caused by interferon-β, a common treatment for multiple sclerosis (MS), according to a new study published by a German research group at the Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, in Würzburg, Germany.
-
+2 +2
Study Finds Physical Activity and Exercise Have Considerable Health Benefits for MS Patients
In a recent study published in the International Journal of Molecular Sciences, a team of researchers from Germany identified an association between increased physical activity and improved mental health in patients with Multiple Sclerosis (MS).
-
+2 +2
Nano-Drugs in Liposomes Could Treat Multiple Sclerosis
Nano-drugs encased in liposomes could one day be used to treat neurological diseases like multiple sclerosis (MS), according to a new study published July 6th in the journal, PloS One.
-
+2 +2
Multiple Sclerosis Research: trial of oral vs. intravenous steroids
"Interestingly, in a fee-for-service healthcare environment neurologists still prefer admitting MSers and using the IV route over the oral route; this way they can charge for seeing their patients daily and for the cost of giving an infusion."
-
+19 +3
The alphabet of months: a year of living with multiple sclerosis
My daughter took her first steps on the day I was diagnosed – a juxtaposition so perfect, so trite, so filled with the tacky artifice of real life that I am generally too ashamed to tell anyone about it. By Christian Donlan.
-
+11 +3
Think of Multiple Sclerosis as a Leaking Swimming Pool
Interesting analogy and unification theory
-
+8 +3
Multiple Sclerosis, Vitamin D, and the Microbiome
The panelists discuss vitamin D levels and multiple sclerosis risk, noting that there is some evidence suggesting vitamin D level has some impact on disease severity in multiple sclerosis. They also briefly discuss the gut microbiome and the potential role played by intestinal flora in disease risk.
-
+2 +2
Report shows people with advanced MS miss out on access to palliative care services. | News | MS Trust - Information, education, research and support
25 June 2015: Report shows people with advanced MS miss out on access to palliative care services.
-
+2 +2
Mitochondria May Play a Role in MS Development and Progression - Multiple Sclerosis News Today
Read about how mitochondria may play a role in multiple sclerosis development and progression.
-
+10 +2
Study Reveals Brain Network Responsible for Cognitive Changes in Multiple Sclerosis
Analysis of the fMRI data revealed that while completing this measure, MS patients showed weaker functional connections with dorsolateral prefrontal cortex.
-
+2 +2
Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis
Pract Neurol doi:10.1136/practneurol-2015-001139
Submit a link
Start a discussion